ArticleCureus2026
Cumulative Sonographic Features From the Morphological Uterus Sonographic Assessment (MUSA) System and Clinical Severity of Adenomyosis in Congolese Women: A Multicenter Study in Kinshasa, Democratic Republic of the Congo.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdenomyosis is increasingly diagnosed noninvasively using transvaginal ultrasound, but the relationship between the cumulative number of standardized sonographic features and clinical severity remains incompletely understood, particularly in African populations. This study aimed to characterize adenomyosis phenotypes according to the revised Morphological Uterus Sonographic Assessment (MUSA) definitions and to evaluate the association between cumulative MUSA feature count and clinical severity. MATERIALS AND
methodsWe conducted a multicenter cross-sectional observational analytical study based on retrospective review of routinely acquired clinical data and ultrasound images from three institutions in Kinshasa, Democratic Republic of the Congo. The source ultrasound examinations were performed as part of routine clinical care between January 2023 and June 16, 2026. Among 2,743 women who had undergone gynecologic ultrasonography, 211 with sonographically diagnosed adenomyosis were included. Nine revised MUSA features were assessed. The primary exposure was cumulative MUSA feature count analyzed as a continuous variable. Multivariable logistic regression models were adjusted for age, body mass index, parity, previous cesarean delivery, recorded concomitant endometriosis, uterine fibroids, and study center.
resultsThe median cumulative MUSA feature count was 5 (interquartile range: 4-6). Severe chronic pelvic pain was present in 60 women (28.4%). Each additional MUSA feature was associated with increased odds of severe chronic pelvic pain (adjusted odds ratio (aOR): 1.65; 95% confidence interval (CI): 1.26-2.18; p<0.001). When direct and indirect feature counts were entered simultaneously, the indirect feature count remained associated with severe chronic pelvic pain (aOR: 1.89; 95% CI: 1.32-2.70; p<0.001), whereas the direct feature count was not statistically significant (aOR: 1.42; 95% CI: 0.97-2.07; p=0.068). Cumulative feature count was not significantly associated with severe dysmenorrhea (aOR: 1.26; 95% CI: 0.97-1.63; p=0.083) or infertility (aOR: 1.09; 95% CI: 0.87-1.38; p=0.448).
conclusionsA higher cumulative MUSA feature count was associated with severe chronic pelvic pain, with the association mainly driven by indirect sonographic features. Cumulative MUSA feature count should be considered an exploratory phenotypic measure rather than a validated severity score. Prospective external validation using standardized image acquisition and independent blinded readers is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.